EFFICIENT GENE DELIVERY TO VASCULAR SMOOTH MUSCLE CELLS USING A NONTOXIC, SYNTHETIC PEPTIDE VECTOR SYSTEM TARGETED TO MEMBRANE INTEGRINS: A FIRST STEP TOWARD THE GENE THERAPY OF CHRONIC REJECTION 1